BioReliance Investor Relations Salaries in Wilmington, DE | Comparably
BioReliance is a leading CRO providing nonclinical testing and contract manufacturing services. read more
EMPLOYEE
PARTICIPANTS
6
TOTAL
RATINGS
126

BioReliance Investor Relations Salaries in Wilmington, DE

The average BioReliance Investor Relations in Wilmington, DE earns an estimated $57,592 annually. BioReliance's Investor Relations compensation is $24,339 less than the US average for a Investor Relations.

In Wilmington, DE, The Communications Department at BioReliance earns $11,044 more on average than the Product Department.

Last updated 2 years ago.

$35k
$47k
$63k
$70k
$109k
$139k
$168k
$57,592
Average Compensation
$57,592
avg. base

Investor Relations Salaries at BioReliance

* estimated salary

Compensation at BioReliance by Department

In Wilmington, DE, The Communications Department averages $11,044 more than the Product Department, and $457 less than the Enterprise Risk Department

Enterprise Risk
$185,536 Avg. total comp.
+$457
Communications
$185,079 Avg. total comp.
Product
$174,035 Avg. total comp.
-$11k

Investor Relations Compensation by Gender (All Companies)

The average female Investor Relations at companies similar size to BioReliance reported making $155,000, while the average male Investor Relations at similar sized companies reported making $50,000.

How Investor Relations at BioReliance Rate Their Compensation

The majority of Investor Relations at BioReliance believe they're compensated fairly. 50% of Investor Relations at BioReliance say they receive annual bonuses, and the vast majority (75%) are satisfied with their benefits. See more compensation ratings at BioReliance

×
Rate your company